These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19344898)

  • 1. A novel missense mutation of ABCA1 in transmembrane alpha-helix in a Japanese patient with Tangier disease.
    Maekawa M; Kikuchi J; Kotani K; Nagao K; Odgerel T; Ueda K; Kawano M; Furukawa Y; Sakurabayashi I
    Atherosclerosis; 2009 Sep; 206(1):216-22. PubMed ID: 19344898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
    Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
    Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of Tangier disease with a novel mutation in the C-terminal region of ATP-binding cassette transporter A1.
    Guan JZ; Tamasawa N; Brunham LR; Matsui J; Murakami H; Suda T; Ochiai S; Tsutsui M; Kudou K; Satoh K; Hayden MR
    Am J Med Genet A; 2004 Nov; 130A(4):398-401. PubMed ID: 15384103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency.
    Albrecht C; Baynes K; Sardini A; Schepelmann S; Eden ER; Davies SW; Higgins CF; Feher MD; Owen JS; Soutar AK
    Biochim Biophys Acta; 2004 May; 1689(1):47-57. PubMed ID: 15158913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency.
    Nishida Y; Hirano K; Tsukamoto K; Nagano M; Ikegami C; Roomp K; Ishihara M; Sakane N; Zhang Z; Tsujii Ki K; Matsuyama A; Ohama T; Matsuura F; Ishigami M; Sakai N; Hiraoka H; Hattori H; Wellington C; Yoshida Y; Misugi S; Hayden MR; Egashira T; Yamashita S; Matsuzawa Y
    Biochem Biophys Res Commun; 2002 Jan; 290(2):713-21. PubMed ID: 11785958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double deletions and missense mutations in the first nucleotide-binding fold of the ATP-binding cassette transporter A1 ( ABCA1) gene in Japanese patients with Tangier disease.
    Guo Z; Inazu A; Yu W; Suzumura T; Okamoto M; Nohara A; Higashikata T; Sano R; Wakasugi K; Hayakawa T; Yoshida K; Suehiro T; Schmitz G; Mabuchi H
    J Hum Genet; 2002; 47(6):325-9. PubMed ID: 12111381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family.
    Maranghi M; Truglio G; Gallo A; Grieco E; Verrienti A; Montali A; Gallo P; Alesini F; Arca M; Lucarelli M
    Biochem Biophys Res Commun; 2019 Jan; 508(2):487-493. PubMed ID: 30503498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
    Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
    Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency.
    Fasano T; Zanoni P; Rabacchi C; Pisciotta L; Favari E; Adorni MP; Deegan PB; Park A; Hlaing T; Feher MD; Jones B; Uzak AS; Kardas F; Dardis A; Sechi A; Bembi B; Minuz P; Bertolini S; Bernini F; Calandra S
    Mol Genet Metab; 2012 Nov; 107(3):534-41. PubMed ID: 22959828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.
    Brousseau ME; Eberhart GP; Dupuis J; Asztalos BF; Goldkamp AL; Schaefer EJ; Freeman MW
    J Lipid Res; 2000 Jul; 41(7):1125-35. PubMed ID: 10884295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol.
    Candini C; Schimmel AW; Peter J; Bochem AE; Holleboom AG; Vergeer M; Dullaart RP; Dallinga-Thie GM; Hovingh GK; Khoo KL; Fasano T; Bocchi L; Calandra S; Kuivenhoven JA; Motazacker MM
    Atherosclerosis; 2010 Dec; 213(2):492-8. PubMed ID: 20880529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology modeling and functional testing of an ABCA1 mutation causing Tangier disease.
    Suetani RJ; Sorrenson B; Tyndall JD; Williams MJ; McCormick SP
    Atherosclerosis; 2011 Oct; 218(2):404-10. PubMed ID: 21763656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis.
    Ishii J; Nagano M; Kujiraoka T; Ishihara M; Egashira T; Takada D; Tsuji M; Hattori H; Emi M
    J Hum Genet; 2002; 47(7):366-9. PubMed ID: 12111371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations in ABCA1 gene in Japanese patients with Tangier disease and familial high density lipoprotein deficiency with coronary heart disease.
    Huang W; Moriyama K; Koga T; Hua H; Ageta M; Kawabata S; Mawatari K; Imamura T; Eto T; Kawamura M; Teramoto T; Sasaki J
    Biochim Biophys Acta; 2001 Jul; 1537(1):71-8. PubMed ID: 11476965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants.
    Quazi F; Molday RS
    J Biol Chem; 2013 Nov; 288(48):34414-26. PubMed ID: 24097981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common and rare ABCA1 variants affecting plasma HDL cholesterol.
    Wang J; Burnett JR; Near S; Young K; Zinman B; Hanley AJ; Connelly PW; Harris SB; Hegele RA
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1983-9. PubMed ID: 10938021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for functional sequence variations and mutations in ABCA1.
    Probst MC; Thumann H; Aslanidis C; Langmann T; Buechler C; Patsch W; Baralle FE; Dallinga-Thie GM; Geisel J; Keller C; Menys VC; Schmitz G
    Atherosclerosis; 2004 Aug; 175(2):269-79. PubMed ID: 15262183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ABCA1 nonsense mutation, R1270X, in Tangier disease associated with an unrecognised bleeding tendency.
    Hooper AJ; Robertson K; Ng L; Kattampallil JS; Latchem D; Willsher PC; Thom J; Baker RI; Burnett JR
    Clin Chim Acta; 2009 Nov; 409(1-2):136-9. PubMed ID: 19723515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.
    Slatter TL; Williams MJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Morison IM; McCormick SP
    Atherosclerosis; 2006 Aug; 187(2):393-400. PubMed ID: 16225879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma amyloid-β in patients with Tangier disease.
    Shahim P; Bochem AE; Mattsson N; Lautner R; Blennow K; Hovingh GK; Motazacker MM; Zetterberg H
    J Alzheimers Dis; 2013; 35(2):307-12. PubMed ID: 23388172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.